Arthur S. Leibowitz
Director · Organogenesis Holdings Inc.
- 2026
- Mar 12, 2026
- 2
Summary
Latest filing:
Arthur S. Leibowitz is Director of Organogenesis Holdings Inc. (ORGO). 2 SEC Form 4 filings on record, most recently on 12 March 2026. Most recent open-market trade: bought $13K of ORGO on 12 March 2026. Lifetime open-market purchases: $13K.
Recent transactions
2The latest 2 SEC Form 4 transactions reported by Arthur S. Leibowitz.
Trading pattern
InsiderAlpha's records for Arthur S. Leibowitz go back to 2026: 2 primary Form 4 filings, an average of 2.0 per year. The typical open-market purchase is $13K (1 buy totaling $13K). The largest single buy on record is $13K of ORGO in 2026. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Arthur S. Leibowitz files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Glenn H. Nussdorf - $3.80M in ORGO purchases and sales in the last 12 months
- Michael Joseph Driscoll - $27K in ORGO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Arthur S. Leibowitz?
Arthur S. Leibowitz is a corporate insider, tracked as Director of Organogenesis Holdings Inc. (ORGO). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Arthur S. Leibowitz last file a Form 4?
The most recent primary Form 4 on record is dated 12 March 2026, one of 2 filings going back to 2026.
Has Arthur S. Leibowitz been buying or selling stock?
Recorded transactions: 1 open-market purchase ($13K) and 0 open-market sales across all tracked filings.